Equities

ELQ SA

ELQ SA

Actions
  • Price (EUR)0.618
  • Today's Change0.00 / 0.00%
  • Shares traded1.00k
  • 1 Year change+186.11%
  • Beta--
Data delayed at least 15 minutes, as of Jun 14 2024 14:29 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ELQ SA, formerly Spark Medical SA, is a Poland-based company engaged in the business support services industry. It offers public and investor relations consulting services for enterprises and is active primarily in the field of Internet, publishing and marketing. It owns such Web portals as IPO.PL, Excluzive.pl and Nowebiuro.pl, among others. It organizes chats, conferences and seminars for management and investors. In addition it provides environmental services, such as waste management and produces medical equipment. It also acts as pharmaceutical preparations wholesaler. It, through a wholly owned subsidiary Florida Investments X Corp, provides support activities to process of investment in residential real estates located in the United States, including searching, buying, modernizing and selling or renting property. The investments are held through special purpose vehicles (SPV) that are owned by the investors. The main shareholder of the Company is Veltoro Sp z o o.

  • Revenue in PLN (TTM)88.41m
  • Net income in PLN8.64m
  • Incorporated2010
  • Employees114.00
  • Location
    ELQ SAul. Jagiellonska 81/83CZESTOCHOWA 42-200PolandPOL
  • Phone+48 343661439
  • Fax+48 343661439
  • Websitehttps://elqsa.pl/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.